2015-2027 Global Oral Antidiabetic Drugs Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

April 2020 | 134 pages | ID: 24F2F173D4DCEN
Maia Research

Abstracts

The worldwide market for Oral Antidiabetic Drugs is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
Sunpharma
Pfizer
Novartis
Novo Nordisk
Eli Lilly
Abbott
Biocon
Sanofi
Merck

Major Types Covered
Sulfonylureas
Meglitinides
Biguanides
Alpha-glucosidase Inhibitors

Major Applications Covered
Hospital
Clinic
Individual
Others

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027

Contents

1 INTRODUCTION

1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
  1.3.1 Market Segment by Type, Application and Marketing Channel
  1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2 KEY FINDINGS OF THE STUDY

3 MARKET DYNAMICS

3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Oral Antidiabetic Drugs Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Oral Antidiabetic Drugs Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis

4 VALUE CHAIN OF THE ORAL ANTIDIABETIC DRUGS MARKET

4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)

5 GLOBAL ORAL ANTIDIABETIC DRUGS MARKET-SEGMENTATION BY TYPE

5.1 Sulfonylureas
5.2 Meglitinides
5.3 Biguanides
5.4 Alpha-glucosidase Inhibitors

6 GLOBAL ORAL ANTIDIABETIC DRUGS MARKET-SEGMENTATION BY APPLICATION

6.1 Hospital
6.2 Clinic
6.3 Individual
6.4 Others

7 GLOBAL ORAL ANTIDIABETIC DRUGS MARKET-SEGMENTATION BY MARKETING CHANNEL

7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel

8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES

8.1 Sunpharma
  8.1.1 Sunpharma Profile
  8.1.2 Sunpharma Sales, Growth Rate and Global Market Share from 2015-2020
  8.1.3 Sunpharma Product/Solution Launches and Enhancements Analysis
  8.1.4 Sunpharma Business Overview/Recent Development/Acquisitions
8.2 Pfizer
  8.2.1 Pfizer Profile
  8.2.2 Pfizer Sales, Growth Rate and Global Market Share from 2015-2020
  8.2.3 Pfizer Product/Solution Launches and Enhancements Analysis
  8.2.4 Pfizer Business Overview/Recent Development/Acquisitions
8.3 Novartis
  8.3.1 Novartis Profile
  8.3.2 Novartis Sales, Growth Rate and Global Market Share from 2015-2020
  8.3.3 Novartis Product/Solution Launches and Enhancements Analysis
  8.3.4 Novartis Business Overview/Recent Development/Acquisitions
8.4 Novo Nordisk
  8.4.1 Novo Nordisk Profile
  8.4.2 Novo Nordisk Sales, Growth Rate and Global Market Share from 2015-2020
  8.4.3 Novo Nordisk Product/Solution Launches and Enhancements Analysis
  8.4.4 Novo Nordisk Business Overview/Recent Development/Acquisitions
8.5 Eli Lilly
  8.5.1 Eli Lilly Profile
  8.5.2 Eli Lilly Sales, Growth Rate and Global Market Share from 2015-2020
  8.5.3 Eli Lilly Product/Solution Launches and Enhancements Analysis
  8.5.4 Eli Lilly Business Overview/Recent Development/Acquisitions
8.6 Abbott
  8.6.1 Abbott Profile
  8.6.2 Abbott Sales, Growth Rate and Global Market Share from 2015-2020
  8.6.3 Abbott Product/Solution Launches and Enhancements Analysis
  8.6.4 Abbott Business Overview/Recent Development/Acquisitions
8.7 Biocon
  8.7.1 Biocon Profile
  8.7.2 Biocon Sales, Growth Rate and Global Market Share from 2015-2020
  8.7.3 Biocon Product/Solution Launches and Enhancements Analysis
  8.7.4 Biocon Business Overview/Recent Development/Acquisitions
8.8 Sanofi
  8.8.1 Sanofi Profile
  8.8.2 Sanofi Sales, Growth Rate and Global Market Share from 2015-2020
  8.8.3 Sanofi Product/Solution Launches and Enhancements Analysis
  8.8.4 Sanofi Business Overview/Recent Development/Acquisitions
8.9 Merck
  8.9.1 Merck Profile
  8.9.2 Merck Sales, Growth Rate and Global Market Share from 2015-2020
  8.9.3 Merck Product/Solution Launches and Enhancements Analysis
  8.9.4 Merck Business Overview/Recent Development/Acquisitions

9 GLOBAL ORAL ANTIDIABETIC DRUGS MARKET-SEGMENTATION BY GEOGRAPHY

10 NORTH AMERICA

10.1 North America Oral Antidiabetic Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Oral Antidiabetic Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Oral Antidiabetic Drugs Production Analysis from 2015-2020
10.4 North America Oral Antidiabetic Drugs Consumption Analysis from 2015-2020
10.5 North America Oral Antidiabetic Drugs Import and Export from 2015-2020
10.6 North America Oral Antidiabetic Drugs Value, Production and Market Share by Type (2015-2020)
10.7 North America Oral Antidiabetic Drugs Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Oral Antidiabetic Drugs by Country (United States, Canada)
  10.8.1 North America Oral Antidiabetic Drugs Sales by Country (2015-2020)
  10.8.2 North America Oral Antidiabetic Drugs Consumption Value by Country (2015-2020)
10.9 North America Oral Antidiabetic Drugs Market PEST Analysis

11 EUROPE

11.1 Europe Oral Antidiabetic Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Oral Antidiabetic Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Oral Antidiabetic Drugs Production Analysis from 2015-2020
11.4 Europe Oral Antidiabetic Drugs Consumption Analysis from 2015-2020
11.5 Europe Oral Antidiabetic Drugs Import and Export from 2015-2020
11.6 Europe Oral Antidiabetic Drugs Value, Production and Market Share by Type (2015-2020)
11.7 Europe Oral Antidiabetic Drugs Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Oral Antidiabetic Drugs by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
  11.8.1 Europe Oral Antidiabetic Drugs Sales by Country (2015-2020)
  11.8.2 Europe Oral Antidiabetic Drugs Consumption Value by Country (2015-2020)
11.9 Europe Oral Antidiabetic Drugs Market PEST Analysis

12 ASIA-PACIFIC

12.1 Asia-Pacific Oral Antidiabetic Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Oral Antidiabetic Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Oral Antidiabetic Drugs Production Analysis from 2015-2020
12.4 Asia-Pacific Oral Antidiabetic Drugs Consumption Analysis from 2015-2020
12.5 Asia-Pacific Oral Antidiabetic Drugs Import and Export from 2015-2020
12.6 Asia-Pacific Oral Antidiabetic Drugs Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Oral Antidiabetic Drugs Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Oral Antidiabetic Drugs by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
  12.8.1 Asia-Pacific Oral Antidiabetic Drugs Sales by Country (2015-2020)
  12.8.2 Asia-Pacific Oral Antidiabetic Drugs Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Oral Antidiabetic Drugs Market PEST Analysis

13 LATIN AMERICA

13.1 Latin America Oral Antidiabetic Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Oral Antidiabetic Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Oral Antidiabetic Drugs Production Analysis from 2015-2020
13.4 Latin America Oral Antidiabetic Drugs Consumption Analysis from 2015-2020
13.5 Latin America Oral Antidiabetic Drugs Import and Export from 2015-2020
13.6 Latin America Oral Antidiabetic Drugs Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Oral Antidiabetic Drugs Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Oral Antidiabetic Drugs by Country (Brazil, Mexico, Argentina, Columbia, Chile)
  13.8.1 Latin America Oral Antidiabetic Drugs Sales by Country (2015-2020)
  13.8.2 Latin America Oral Antidiabetic Drugs Consumption Value by Country (2015-2020)
13.9 Latin America Oral Antidiabetic Drugs Market PEST Analysis

14 MIDDLE EAST & AFRICA

14.1 Middle East & Africa Oral Antidiabetic Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Oral Antidiabetic Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Oral Antidiabetic Drugs Production Analysis from 2015-2020
14.4 Middle East & Africa Oral Antidiabetic Drugs Consumption Analysis from 2015-2020
14.5 Middle East & Africa Oral Antidiabetic Drugs Import and Export from 2015-2020
14.6 Middle East & Africa Oral Antidiabetic Drugs Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Oral Antidiabetic Drugs Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Oral Antidiabetic Drugs by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
  14.8.1 Middle East & Africa Oral Antidiabetic Drugs Sales by Country (2015-2020)
  14.8.2 Middle East & Africa Oral Antidiabetic Drugs Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Oral Antidiabetic Drugs Market PEST Analysis

15 FUTURE FORECAST OF THE GLOBAL ORAL ANTIDIABETIC DRUGS MARKET FROM 2020-2027

15.1 Future Forecast of the Global Oral Antidiabetic Drugs Market from 2020-2027 Segment by Region
15.2 Global Oral Antidiabetic Drugs Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Oral Antidiabetic Drugs Consumption and Growth Rate Forecast by Application (2020-2027)

16 APPENDIX

16.1 Methodology
16.2 Research Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Global Oral Antidiabetic Drugs Market Value ($) and Growth Rate of Oral Antidiabetic Drugs from 2015-2027
Global Oral Antidiabetic Drugs Production and Growth Rate Segment by Product Type from 2015-2027
Global Oral Antidiabetic Drugs Consumption and Growth Rate Segment by Application from 2015-2027
Figure Oral Antidiabetic Drugs Picture
Table Product Specifications of Oral Antidiabetic Drugs
Table Driving Factors for this Market
Table Industry News of Oral Antidiabetic Drugs Market
Figure Value Chain Status of Oral Antidiabetic Drugs
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Oral Antidiabetic Drugs Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Oral Antidiabetic Drugs Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Sulfonylureas of Oral Antidiabetic Drugs
Figure Meglitinides of Oral Antidiabetic Drugs
Figure Biguanides of Oral Antidiabetic Drugs
Figure Alpha-glucosidase Inhibitors of Oral Antidiabetic Drugs
Table Global Oral Antidiabetic Drugs Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Oral Antidiabetic Drugs Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Hospital of Oral Antidiabetic Drugs
Figure Clinic of Oral Antidiabetic Drugs
Figure Individual of Oral Antidiabetic Drugs
Figure Others of Oral Antidiabetic Drugs
Table Global Oral Antidiabetic Drugs Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Oral Antidiabetic Drugs Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Oral Antidiabetic Drugs
Figure Online Channel of Oral Antidiabetic Drugs
Table Sunpharma Profile (Company Name, Plants Distribution, Sales Region)
Figure Sunpharma Sales and Growth Rate from 2015-2020
Figure Sunpharma Revenue ($) and Global Market Share from 2015-2020
Table Sunpharma Oral Antidiabetic Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Pfizer Profile (Company Name, Plants Distribution, Sales Region)
Figure Pfizer Sales and Growth Rate from 2015-2020
Figure Pfizer Revenue ($) and Global Market Share from 2015-2020
Table Pfizer Oral Antidiabetic Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Novartis Profile (Company Name, Plants Distribution, Sales Region)
Figure Novartis Sales and Growth Rate from 2015-2020
Figure Novartis Revenue ($) and Global Market Share from 2015-2020
Table Novartis Oral Antidiabetic Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Novo Nordisk Profile (Company Name, Plants Distribution, Sales Region)
Figure Novo Nordisk Sales and Growth Rate from 2015-2020
Figure Novo Nordisk Revenue ($) and Global Market Share from 2015-2020
Table Novo Nordisk Oral Antidiabetic Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Eli Lilly Profile (Company Name, Plants Distribution, Sales Region)
Figure Eli Lilly Sales and Growth Rate from 2015-2020
Figure Eli Lilly Revenue ($) and Global Market Share from 2015-2020
Table Eli Lilly Oral Antidiabetic Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Abbott Profile (Company Name, Plants Distribution, Sales Region)
Figure Abbott Sales and Growth Rate from 2015-2020
Figure Abbott Revenue ($) and Global Market Share from 2015-2020
Table Abbott Oral Antidiabetic Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Biocon Profile (Company Name, Plants Distribution, Sales Region)
Figure Biocon Sales and Growth Rate from 2015-2020
Figure Biocon Revenue ($) and Global Market Share from 2015-2020
Table Biocon Oral Antidiabetic Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Sanofi Profile (Company Name, Plants Distribution, Sales Region)
Figure Sanofi Sales and Growth Rate from 2015-2020
Figure Sanofi Revenue ($) and Global Market Share from 2015-2020
Table Sanofi Oral Antidiabetic Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Merck Profile (Company Name, Plants Distribution, Sales Region)
Figure Merck Sales and Growth Rate from 2015-2020
Figure Merck Revenue ($) and Global Market Share from 2015-2020
Table Merck Oral Antidiabetic Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Oral Antidiabetic Drugs Production Value ($) by Region from 2015-2020
Table Global Oral Antidiabetic Drugs Production Value Share by Region from 2015-2020
Table Global Oral Antidiabetic Drugs Production by Region from 2015-2020
Table Global Oral Antidiabetic Drugs Consumption Value ($) by Region from 2015-2020
Table Global Oral Antidiabetic Drugs Consumption by Region from 2015-2020
Table North America Oral Antidiabetic Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Oral Antidiabetic Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Oral Antidiabetic Drugs Import and Export from 2015-2020
Table North America Oral Antidiabetic Drugs Value ($) by Type (2015-2020)
Table North America Oral Antidiabetic Drugs Production by Type (2015-2020)
Table North America Oral Antidiabetic Drugs Consumption by Application (2015-2020)
Table North America Oral Antidiabetic Drugs Consumption by Country (2015-2020)
Table North America Oral Antidiabetic Drugs Consumption Value ($) by Country (2015-2020)
Figure North America Oral Antidiabetic Drugs Market PEST Analysis
Table Europe Oral Antidiabetic Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Oral Antidiabetic Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Oral Antidiabetic Drugs Import and Export from 2015-2020
Table Europe Oral Antidiabetic Drugs Value ($) by Type (2015-2020)
Table Europe Oral Antidiabetic Drugs Production by Type (2015-2020)
Table Europe Oral Antidiabetic Drugs Consumption by Application (2015-2020)
Table Europe Oral Antidiabetic Drugs Consumption by Country (2015-2020)
Table Europe Oral Antidiabetic Drugs Consumption Value ($) by Country (2015-2020)
Figure Europe Oral Antidiabetic Drugs Market PEST Analysis
Table Asia-Pacific Oral Antidiabetic Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Oral Antidiabetic Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Oral Antidiabetic Drugs Import and Export from 2015-2020
Table Asia-Pacific Oral Antidiabetic Drugs Value ($) by Type (2015-2020)
Table Asia-Pacific Oral Antidiabetic Drugs Production by Type (2015-2020)
Table Asia-Pacific Oral Antidiabetic Drugs Consumption by Application (2015-2020)
Table Asia-Pacific Oral Antidiabetic Drugs Consumption by Country (2015-2020)
Table Asia-Pacific Oral Antidiabetic Drugs Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Oral Antidiabetic Drugs Market PEST Analysis
Table Latin America Oral Antidiabetic Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Oral Antidiabetic Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Oral Antidiabetic Drugs Import and Export from 2015-2020
Table Latin America Oral Antidiabetic Drugs Value ($) by Type (2015-2020)
Table Latin America Oral Antidiabetic Drugs Production by Type (2015-2020)
Table Latin America Oral Antidiabetic Drugs Consumption by Application (2015-2020)
Table Latin America Oral Antidiabetic Drugs Consumption by Country (2015-2020)
Table Latin America Oral Antidiabetic Drugs Consumption Value ($) by Country (2015-2020)
Figure Latin America Oral Antidiabetic Drugs Market PEST Analysis
Table Middle East & Africa Oral Antidiabetic Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Oral Antidiabetic Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Oral Antidiabetic Drugs Import and Export from 2015-2020
Table Middle East & Africa Oral Antidiabetic Drugs Value ($) by Type (2015-2020)
Table Middle East & Africa Oral Antidiabetic Drugs Production by Type (2015-2020)
Table Middle East & Africa Oral Antidiabetic Drugs Consumption by Application (2015-2020)
Table Middle East & Africa Oral Antidiabetic Drugs Consumption by Country (2015-2020)
Table Middle East & Africa Oral Antidiabetic Drugs Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Oral Antidiabetic Drugs Market PEST Analysis
Table Global Oral Antidiabetic Drugs Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Oral Antidiabetic Drugs Production and Growth Rate Forecast by Region (2020-2027)
Table Global Oral Antidiabetic Drugs Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Oral Antidiabetic Drugs Production and Growth Rate Forecast by Type (2020-2027)
Table Global Oral Antidiabetic Drugs Consumption and Growth Rate Forecast by Application (2020-2027)